Avalo Therapeutics, Inc. (AVTX)
19.31
-0.28
(-1.43%)
USD |
NASDAQ |
Aug 31, 16:00
19.31
0.00 (0.00%)
After-Hours: 20:00
Avalo Therapeutics Cash and Short Term Investments (Quarterly) : 400.32M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 400.32M |
| March 31, 2026 | 82.14M |
| December 31, 2025 | 98.37M |
| September 30, 2025 | 111.71M |
| June 30, 2025 | 113.28M |
| March 31, 2025 | 125.11M |
| December 31, 2024 | 134.56M |
| September 30, 2024 | 81.90M |
| June 30, 2024 | 93.43M |
| March 31, 2024 | 110.18M |
| December 31, 2023 | 7.416M |
| September 30, 2023 | 10.18M |
| June 30, 2023 | 6.322M |
| March 31, 2023 | 16.75M |
| December 31, 2022 | 13.19M |
| September 30, 2022 | 17.00M |
| June 30, 2022 | 11.26M |
| March 31, 2022 | 38.57M |
| December 31, 2021 | 54.64M |
| September 30, 2021 | 71.67M |
| June 30, 2021 | 40.48M |
| March 31, 2021 | 38.44M |
| December 31, 2020 | 18.96M |
| Date | Value |
|---|---|
| September 30, 2020 | 33.52M |
| June 30, 2020 | 45.42M |
| March 31, 2020 | 20.43M |
| December 31, 2019 | |
| September 30, 2019 | 5.353M |
| June 30, 2019 | 9.413M |
| March 31, 2019 | 16.20M |
| December 31, 2018 | 10.66M |
| September 30, 2018 | 6.875M |
| June 30, 2018 | 2.189M |
| March 31, 2018 | 2.538M |
| December 31, 2017 | 2.474M |
| September 30, 2017 | 23.98M |
| June 30, 2017 | 5.474M |
| March 31, 2017 | 3.022M |
| December 31, 2016 | 5.139M |
| September 30, 2016 | 8.903M |
| June 30, 2016 | 11.94M |
| March 31, 2016 | 16.66M |
| December 31, 2015 | 21.22M |
| September 30, 2015 | 3.308M |
| June 30, 2015 | 6.201M |
| March 31, 2015 | 8.657M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Incyte Corp. | 4.536B |
| AbbVie, Inc. | 6.569B |
| Rezolute, Inc. | 120.27M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |